GlassScriptPhysician profile
Alice He
NPI 1972992634
$5,237.04
in general payments reported to CMS, 2019-2025
31 companies · $1,802 in 2025
The $1,802 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $720 · 2023: $1,510 · 2024: $1,205 · 2025: $1,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,516.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $667.34 | 2022-2025 | Tremfya |
| Abbvie INC. | $638.92 | 2022-2025 | |
| Genzyme Corporation | $457.75 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $388.99 | 2023-2025 | |
| Inari Medical, INC. | $362.36 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Incyte Corporation | $327.76 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $320.30 | 2022-2025 | Dupixent |
| Lilly USA, LLC | $223.24 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $199.48 | 2022-2025 | Blu-U, Odomzo, Ilumya |
| Pfizer INC. | $189.09 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $180.82 | 2022-2024 | Sotyktu |
| Amgen INC. | $174.07 | 2022-2025 | Otezla, Otezla |
| Leo Pharma INC. | $144.44 | 2022-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $107.91 | 2023-2025 | Nemluvio, Oracea, Aklief |
| Ucb, INC. | $107.21 | 2024-2025 | Bimzelx |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $98.80 | 2022-2024 | Vtama |
| Verrica Pharmaceuticals INC. | $96.01 | 2023-2024 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.35 | 2024-2025 | Spevigo |
| Strata Skin Sciences, INC. | $77.19 | 2023 | Xtrac |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $57.54 | 2023-2025 | Jublia, Cabtreo, Siliq |
| Arcutis Biotherapeutics, INC. | $53.60 | 2023-2024 | Zoryve |
| Almirall LLC | $44.54 | 2022-2025 | Klisyri |
| Kyowa Kirin, INC. | $42.71 | 2023-2024 | Poteligeo |
| Nabriva Therapeutics, Plc | $42.15 | 2022 | |
| Springworks Therapeutics, INC. | $25.89 | 2025 | Gomekli |
| Journey Medical Corporation | $24.09 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $20.77 | 2022 | |
| Glaxosmithkline, LLC. | $20.22 | 2023 | Arexvy, Shingrix |
| Alexion Pharmaceuticals, INC. | $18.69 | 2025 | Koselugo |
| Biofrontera INC. | $18.39 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Botanix Sb INC | $14.42 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.